![]() |
Volumn 56, Issue 4, 2001, Pages 331-341
|
Levobupivacaine
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANALGESIC AGENT;
BUPIVACAINE;
CLONIDINE;
FENTANYL;
ION CHANNEL;
KETOROLAC;
LEVOBUPIVACAINE;
LIDOCAINE;
LOCAL ANESTHETIC AGENT;
MORPHINE;
PLACEBO;
ROPIVACAINE;
ANALGESIC ACTIVITY;
AREA UNDER THE CURVE;
CARDIOTOXICITY;
CENTRAL NERVOUS SYSTEM DISEASE;
CHIRALITY;
CLINICAL TRIAL;
DOSE TIME EFFECT RELATION;
DRUG CLEARANCE;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
DRUG POTENTIATION;
DRUG PROTEIN BINDING;
DRUG SAFETY;
HEART CONTRACTION;
HEART ELECTROPHYSIOLOGY;
HUMAN;
ISOMER;
LD 50;
LOCAL ANESTHESIA;
NOMENCLATURE;
NONHUMAN;
OBSTETRIC ANESTHESIA;
PAIN ASSESSMENT;
PEDIATRIC ANESTHESIA;
REGIONAL ANESTHESIA;
REVIEW;
STEREOCHEMISTRY;
STEREOISOMERISM;
STRUCTURE ACTIVITY RELATION;
TOXICITY TESTING;
ANESTHESIA, CONDUCTION;
ANESTHETICS, LOCAL;
ANIMALS;
BUPIVACAINE;
HUMANS;
STEREOISOMERISM;
|
EID: 0035067807
PISSN: 00032409
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1365-2044.2001.01964.x Document Type: Review |
Times cited : (146)
|
References (59)
|